All are on the rise in the United States and, with the increasing prevalence of obesity and diabetes, have been described as an epidemic. Did you know that in 2013 the leading cause of death was cardiovascular disease? This affects us all. People either have heart disease, will get heart disease, or know someone who has heart disease. The demand is high for a greater understanding of how cardiovascular disease develops and for new and better treatments. This is the mission of the Vascular Biology Center. We have brought together an internationally recognized team of experts determined to make breakthroughs in the prevention and treatment of cardiovascular disease. Our field is developing rapidly, our science is critical, not only for the health of our country, but the rest of the world.
|
Congratulations Dr. Rudolf Lucas of the Vascular Biology CenterRecipient of the 2018 Distinguished Researcher Award.
|
 |
Congratulations Dr. Gabor Csanyi of the Vascular Biology CenterRecipient of the 2018 Emerging Scientist Award. |
|
Getting leptin levels “just right” may provide cardiovascular protectionDrs. Thiago Bruder do Nascimento and Eric Belin de Chantemele featured in Jagwire, |
|
Dr. Ruth Caldwell receives RO1National Institute of Health Research Project Grant (R01) Award |
|
Sex Differences in Mechanisms of Hypertension Associated with ObesityEric Belin de Chantemele, PhD interviewed at Joint Hypertension 2018 Scientific Sessions
- |
 |
New target is an apparent triple threat to pneumoniaDr. Rudolf Lucas of the VBC featured on WJBF News. |
|
Il-man Kim, PhD, Associate Professor, awarded American Heart Association Transformational Project Award.“The novel role of microRNA-532-5p/press23 axis in regulating cardiac vascularization during acute myocardial infarction” |
|
